National Stroke Education Center (NSEC) Initiative: Advanced Stroke Imaging and Subtleties in the Neurologic Exam

Friday, January 14, 2022, 12:00 AM - Saturday, January 14, 2023, 11:59 PM

AMA PRA Category 1 Credits™ (1.50 hours), AMA PRA Category 1 Credits™ Designated (1.50 hours)

This National Stroke Education Center (NSEC) program serves as a state of the art description of the current landscape of acute stroke care. The faculty members presenting in this program are experts in stroke management with backgrounds in stroke research, emergency medicine, neurocritical care, and neurology. Through this educational program, healthcare professionals (HCPs) will improve and enhance their knowledge, competence, and clinical performance in acute ischemic stroke (AIS) care as they distill clinical data into practice-changing outcomes. This program presents the foundational literature in acute stroke care. It begins with a review of the analysis of acute stroke trials, including the application of outcomes measures, the number needed to treat (NNT) and number needed to harm (NNH), and the relevance of the fragility index. The indications for urgent anticoagulation (heparin) after ischemic stroke are discussed, with a focus on the risks and benefits for different types of patients. The pivotal 1995 NINDS stroke trial is presented and examined in the context of other major stroke trials. Finally, the evolution of endovascular therapy for acute ischemic stroke as well as its future directions is presented.

To view this enduring material, please go to: www.strokejourney.com

SYSTEM REQUIREMENTS
A computer or smartphone with broadband internet access with cookies enabled, sound card and speakers are required. Smartphone mobile data rates will apply if viewing without a Wi-Fi mobile connection. Adobe PDF Reader is necessary to print your certificate and this plug-in is free and available from the Adobe website.

FEE STATEMENT
This activity is FREE to all participants.

INSTRUCTIONS FOR COMPLETION
During the period 12/15/2020 thru 12/15/2021, registered participants wishing to receive continuing education credit for this activity must follow these steps:
1. Read the learning objectives and faculty disclosures.
2. Answer a pre-program question.
3. View the program.
4. Complete the post-test with a score of 100%.
5. Complete activity evaluation.
6. Apply for credit and either bank your credits or print your certificate.

1. Discuss methods for analyzing data and conclusions in acute ischemic stroke trials
2. Describe the indications for urgent anticoagulation (heparin) after acute ischemic stroke
3. Discuss the critical aspect of time to treatment associated with the management of acute ischemic stroke
4. Describe the role of endovascular therapy (EVT) for acute ischemic stroke

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati, EMCREG-International and TotalCME, Inc. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

The opinions expressed during this activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development. 

Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity. 

No faculty are available for this activity at this time.

This educational activity is supported by an educational grant from Genentech.